Browse studies

Find your next paid study

1 recruiting study matching your filters

Phase 1/2 Trial of PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma (PRiME II)

This is a multisite, phase I/II clinical trial in children and young adults with newly-diagnosed high-grade glioma (HGG), diffuse midline glioma (DMG) and recu…

Diffuse Midline GliomaDiffuse Midline High-grade GliomaMedulloblastoma+1 more

Washington University School of MedicineNCT06639607